CCCC Stock Analysis: Buy, Sell, or Hold?
CCCC - C4 Therapeutics, Inc.
$4.35
0.21 (5.07%)
▲
5d:
+0.0%
30d:
+4.32%
90d:
+53.17%
BUY
MODERATE Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 06, 2026
29d
Get Alerted When CCCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CCCC this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CCCC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CCCC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CCCC is currently trading at $4.35, which is considered slightly high relative to its 30-day fair value range of $3.85 to $4.38.
Technical Outlook: Technically, CCCC is in a strong uptrend. Immediate support is located at $3.96, while resistance sits at $5.17. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.33 (+206.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCCC is in a strong uptrend. Immediate support is located at $3.96, while resistance sits at $5.17. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.33 (+206.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.85 -
$4.38
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- BULLISH: Trading 206.5% below Wall St target ($13.33)
Trading Range Analysis
30-Day Trading Range
$3.85 -
$4.38
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.97
Resistance Level
$5.17
Current Trend
Strong Uptrend
Technical data as of
Jul 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.18
Wall Street Target
$13.33
(+206.5%)
Revenue Growth (YoY)
-15.0%
Profit Margin
-297.8%
Share & Embed Analysis
Last updated: July 07, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Leonard Reyno
SELL
10000 shares
2026-01-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 61 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 69 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 64 BUY |
